Trials / Completed
CompletedNCT01905540
A Relative Bioavailability Study of SSP-004184AQ (Magnesium Salt) and SSP-004184SS (Disodium Salt)
A Phase 1, Open-label, Randomized, 3-Period, Relative Bioavailability Study Comparing the Pharmacokinetics of SSP-004184AQ (Magnesium Salt) to SSP-004184SS (Disodium Salt) Each Administered as a Single Dose and as Two Doses of SSP-004184 (Free Acid) in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate the relative bioavailability of the new SSP-004184SS capsule formulation compared to the original SSP-004184AQ drug plus excipients formulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SSP-004184AQ | Magnesium salt |
| DRUG | SSP-004184SS | Disodium salt |
Timeline
- Start date
- 2013-08-05
- Primary completion
- 2013-09-20
- Completion
- 2013-09-20
- First posted
- 2013-07-23
- Last updated
- 2021-07-19
- Results posted
- 2014-12-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01905540. Inclusion in this directory is not an endorsement.